Volume 14, Number 5—May 2008
Scale-up of Multidrug-Resistant Tuberculosis Laboratory Services, Peru
|Step||Median baseline turnaround time, d||Strategies used||Goal turnaround time, d|
|From time DST processed to DST result at INS||81||Decentralize conventional and rapid DST methods||21|
|From receipt of DST result at intermediate laboratory to receipt of DST result at health establishment||6||Implement laboratory information system linking health centers, regional and national laboratories; improve transport of samples from health centers to regional laboratories||1|
|From receipt of DST result at health establishment to patient reevaluation with DST result||33||Train local providers to improve identification and referral of patients in need of MDR TB treatment; increase frequency of MDR TB treatment approval meetings; create new national culture/DST request form with DST indicators||7|
*DST, drug susceptibility testing; INS, Instituto Nacional de Salud; MDR TB, multidrug-resistant tuberculosis.
Page created: July 08, 2010
Page updated: July 08, 2010
Page reviewed: July 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.